These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 9379061)
1. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. Lamkhioued B; Renzi PM; Abi-Younes S; Garcia-Zepada EA; Allakhverdi Z; Ghaffar O; Rothenberg MD; Luster AD; Hamid Q J Immunol; 1997 Nov; 159(9):4593-601. PubMed ID: 9379061 [TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Ying S; Robinson DS; Meng Q; Rottman J; Kennedy R; Ringler DJ; Mackay CR; Daugherty BL; Springer MS; Durham SR; Williams TJ; Kay AB Eur J Immunol; 1997 Dec; 27(12):3507-16. PubMed ID: 9464841 [TBL] [Abstract][Full Text] [Related]
3. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin. Xu J; Jiang F; Nayeri F; Zetterström O Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492 [TBL] [Abstract][Full Text] [Related]
4. BAL eotaxin and IL-5 in asthma, and the effects of inhaled corticosteroid and beta2 agonist. Feltis BN; Reid DW; Ward C; Walters EH Respirology; 2004 Nov; 9(4):507-13. PubMed ID: 15612963 [TBL] [Abstract][Full Text] [Related]
5. Eotaxin expression and eosinophilic inflammation in asthma. Mattoli S; Stacey MA; Sun G; Bellini A; Marini M Biochem Biophys Res Commun; 1997 Jul; 236(2):299-301. PubMed ID: 9240429 [TBL] [Abstract][Full Text] [Related]
7. Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation. Brown JR; Kleimberg J; Marini M; Sun G; Bellini A; Mattoli S Clin Exp Immunol; 1998 Nov; 114(2):137-46. PubMed ID: 9822268 [TBL] [Abstract][Full Text] [Related]
8. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia. Jahnsen FL; Haye R; Gran E; Brandtzaeg P; Johansen FE J Immunol; 1999 Aug; 163(3):1545-51. PubMed ID: 10415058 [TBL] [Abstract][Full Text] [Related]
9. IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts. Létuvé S; Lajoie-Kadoch S; Audusseau S; Rothenberg ME; Fiset PO; Ludwig MS; Hamid Q J Allergy Clin Immunol; 2006 Mar; 117(3):590-6. PubMed ID: 16522458 [TBL] [Abstract][Full Text] [Related]
10. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. Ying S; Meng Q; Zeibecoglou K; Robinson DS; Macfarlane A; Humbert M; Kay AB J Immunol; 1999 Dec; 163(11):6321-9. PubMed ID: 10570327 [TBL] [Abstract][Full Text] [Related]
11. Eotaxin-2 regulates newly produced and CD34 airway eosinophils after allergen exposure. Rådinger M; Johansson AK; Sitkauskiene B; Sjöstrand M; Lötvall J J Allergy Clin Immunol; 2004 Jun; 113(6):1109-16. PubMed ID: 15208592 [TBL] [Abstract][Full Text] [Related]
12. Exhaled breath condensate levels of eotaxin and macrophage-derived chemokine in stable adult asthma patients. Ko FW; Lau CY; Leung TF; Wong GW; Lam CW; Lai CK; Hui DS Clin Exp Allergy; 2006 Jan; 36(1):44-51. PubMed ID: 16393265 [TBL] [Abstract][Full Text] [Related]
13. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate. Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370 [TBL] [Abstract][Full Text] [Related]
14. Contribution of eotaxin-1 to eosinophil chemotactic activity of moderate and severe asthmatic sputum. Dent G; Hadjicharalambous C; Yoshikawa T; Handy RL; Powell J; Anderson IK; Louis R; Davies DE; Djukanovic R Am J Respir Crit Care Med; 2004 May; 169(10):1110-7. PubMed ID: 15001461 [TBL] [Abstract][Full Text] [Related]
15. Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge. Ravensberg AJ; Ricciardolo FL; van Schadewijk A; Rabe KF; Sterk PJ; Hiemstra PS; Mauad T J Allergy Clin Immunol; 2005 Apr; 115(4):779-85. PubMed ID: 15805998 [TBL] [Abstract][Full Text] [Related]
16. Eotaxin expression after segmental allergen challenge in subjects with atopic asthma. Lilly CM; Nakamura H; Belostotsky OI; Haley KJ; Garcia-Zepeda EA; Luster AD; Israel E Am J Respir Crit Care Med; 2001 Jun; 163(7):1669-75. PubMed ID: 11401892 [TBL] [Abstract][Full Text] [Related]
17. Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa. Fukakusa M; Bergeron C; Tulic MK; Fiset PO; Al Dewachi O; Laviolette M; Hamid Q; Chakir J J Allergy Clin Immunol; 2005 Feb; 115(2):280-6. PubMed ID: 15696082 [TBL] [Abstract][Full Text] [Related]
18. IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. Pope SM; Brandt EB; Mishra A; Hogan SP; Zimmermann N; Matthaei KI; Foster PS; Rothenberg ME J Allergy Clin Immunol; 2001 Oct; 108(4):594-601. PubMed ID: 11590387 [TBL] [Abstract][Full Text] [Related]